September 28, 2025Research Journal of Pharmacy and Technology

Unveiling the Medicinal Benefits, Contemporary Phyto-pharmacological Potentials and In- silico Studies of Achyranthes aspera

View Full Paper

Ask AI

Bookmark

Achyranthes aspera shows potential as an anticancer agent, particularly effective against pancreatic cancer.
In silico studies indicate that compounds from Achyranthes aspera interact favorably with mutated BRAF and NRAS genes.
Molecular docking reveals high binding affinity of saponins for COX-2 and 5-LOX enzymes involved in inflammation.
ADMET analysis of bioactive compounds confirms their promising drug-like properties and safety profiles.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This research uncovers the phytopharmacological benefits and in silico studies of Achyranthes aspera, highlighting its anti-inflammatory and anticancer properties.

Cite This Study

Gupta et al. (2025) studied this question.

synapsesocial.com/papers/68d90a0641e1c178a14f628b https://doi.org/10.52711/0974-360x.2025.00576

View Full Paper

Ask AI

Bookmark

Implication

This research uncovers the phytopharmacological benefits and in silico studies of Achyranthes aspera, highlighting its anti-inflammatory and anticancer properties.

Unveiling the Medicinal Benefits, Contemporary Phyto-pharmacological Potentials and In- silico Studies of Achyranthes aspera

Key Points

Discussion

Implication

Cite This Study

Unveiling the Medicinal Benefits, Contemporary Phyto-pharmacological Potentials and In- silico Studies of Achyranthes aspera

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider